[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 23, Issue 1 (Bimonthly 2019) ::
Feyz 2019, 23(1): 61-67 Back to browse issues page
Study of the correlation between CYP1A1 gene promoter methylation and smoking in gastric cancer patients
Leili Sadeghi-Amiri , Ali Barzegar * , Novin Nikbakhsh-Zati , Pooyan Mehraban
Department of Basic Sciences, Sari Agricultural Sciences and Natural Resources University, Sari, I. R. Iran. , alibar647@yahoo.com
Abstract:   (417 Views)
Background: Gastric cancer is one of the main causes of cancer related deaths particularly in northern parts of Iran. It has been recently attributed to the increased application of agricultural pesticides in these areas. CYP1A1 is the prototype member of the cytochrome P450 detoxifying enzymes that its gene expression alterations as a result of genetic or epigenetic changes, has been verified to have significant role on gastric cancer incidence.
Materials and Methods: In this cross-sectional study, genomic DNA of tumoral and normal stomach tissues was extracted by phenol chloroform protocol and was subjected to bisulfite conversion by the EpiTech DNA Bisulfite kit. CpG-rich regions of the CYP1A1 gene promoter was amplified using specific primers and subsequently was sequenced in both directions using direct bisulfite Sanger sequencing method. Methylation rate of the individual CpGs was calculated and its correlation with demographic features was estimated by Spearman's test.
Results: Results showed a significant positive correlation between promoter methylation of the CYP1A1 gene, particularly those CpGs existing in Xenobiotic response elements (XRE) consensus sequence, and smoking habit as well as familial history of gastric cancer. However, increasing age showed no significant effect on the methylation rate of the CYP1A1 gene promoter.
Conclusion: Smoking and familial history of gastric cancer showed positive correlation with CYP1A1 gene promoter methylation. Screening of the CYP1A1 gene promoter methylation in smokers and individuals having positive familial history of disease may be used as a marker for gastric cancer diagnosis.
Keywords: CYP1A1, Methylation, Gastric cancer, Smoking tobacco
Full-Text [PDF 358 kb]   (83 Downloads)    
Type of Study: Research | Subject: medicine, paraclinic
Received: 2018/10/29 | Accepted: 2019/01/13 | Published: 2019/04/17
References
1. Mousavi SM, Gouya MM, Ramazani R, Davanlou M, Hajsadeghi N, Seddighi Z. Cancer incidence and mortality in Iran. Ann Oncol 2008; 20(3): 56-63.
2. Rugge M, Fassan M, Graham DY. Epi‌de‌m‌iology of gastric cancer. In Gastric Cancer: Sp‌r‌inger, Cham; 2015; 23-34.
3. Sadjadi A, Malekzadeh R, Derakhshan MH, Se‌pehr A, Nouraie M, Sotoudeh M, et al. Cancer occ‌u‌rrence in Ardabil: Results of a population‐based Cancer Registry from Iran. Int J Cancer 2003; 107(1): 113-8.
4. Pakseresht M, Forman D, Malekzadeh R, Yazdanbod A, West RM, Greenwood DC, et al. Dietary habits and gastric cancer risk in north-west Iran. Cancer Causes Control 2011; 22(5): 725-36.
5. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global Cancer Statistics. CA Cancer J Clin 2011; 61(2): 69-90.
6. Sergentanis TN, Economopoulos KP. Four poly‌morphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 2010; 122(2): 459-69.
7. Nishimoto IN, Hanaoka T, Sugimura H, Nagura K, Ihara M, Li XJ, et al. Cytochrome P450 2E1 polymorphism in gastric cancer in Brazil: case-control studies of Japanese Brazilians and non-Japanese Brazilians. Cancer Epidemiol Biomarkers Prev 2000; 9(7): 675-80.
8. Cai L, Zheng ZL, Zhang ZF. Cytochrome p450 2E1 polymorphisms and the risk of gastric cardia cancer. World J Gastroenterol 2005; 11(12): 1867–71.
9. Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer 2004; 4(2): 143.
10. Toutounchi M, Shahhosseini M, Moumeni MM, Baharvand H. Epigenetic of stem cells. Cell J (Yakhteh) 2007; 9(1): 51-66.
11. Ladeiras-Lopes R, Pereira AK, Nogueira A, Pinheiro-Torres T, Pinto I, Santos-Pereira R, et al. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control 2008; 19(7): 689-701.
12. Breitling LP, Yang R, Korn B, Burwinkel B, Brenner H. Tobacco-smoking-related differential DNA methylation: 27K discovery and replication. Am J Hum Genet 2011; 88(4): 450-7
13. Breton CV, Byun HM, Wenten M, Pan F, Yang A, Gilliland FD. Prenataltobacco smoke exp‌osure affects global and gene-specific DNA methy‌lation. Am J Respir Critical Care Med 2009; 180(5): 462-7.
14. Walsh AA, Szklarz GD, Scott EE. Human cytochrome P450 1A1 structure and utility in understanding drug and xenobiotic metabolism. J Biol Chem 2013; 288(18): 12932-43.
15. Kress S, Reichert J, Schwarz M. Functional analysis of the human cytochrome P4501A1 (CY‌P1‌A1) gene enhancer. Eur J Biochem 1998; 258(2): 803-12.
16. Kim JH, Sherman ME, Curriero FC, Gue‌ngerich FP, Strickland PT, Sutter TR. Expression of cytochromes P450 1A1 and 1B1 in human lung from smokers, non-smokers, and ex-smokers. Toxicol Appl Pharmacol 2004; 199(3): 210-9.
17. Sharma R, Panda NK, Khullar M. Hyper‌methylation of carcinogen metabolism genes, CY‌P1A1, CYP2A13 and GSTM1 genes in head and neck cancer. Oral Dis 2010; 16(7): 668-73.
18. Breitling LP, Yang R, Korn B, Burwinkel B, Brenner H. Tobacco-smoking-related differential DNA methylation: 27K discovery and replication. Am J Hum Genet 2011; 88(4): 450-7.
19. Nukaya M, Bradfield CA. Conserved genomic structure of the Cyp1a1 and Cyp1A2 loci and their dioxin responsive elements cluster. Biochem Pharmacol 2009; 77(4): 654-9.
20. Nakajima M, Iwanari M, Yokoi T. Effects of histone deacetylation and DNA methylation on the constitutive and TCDD-inducible expressions of the human CYP1 family in MCF-7 and HeLa cells. Toxicol Lett 2003; 144(2): 247-56.
21. Tekpli X, Zienolddiny S, Skaug V, Stangeland L, Haugen A, Mollerup S. DNA methylation of the CYP1A1 enhancer is associated with smo‌ki‌ng‌induced genetic alterations in human lung. Int J Cancer 2012; 131(7): 1509-16.
22. Anttila S, Hakkola J, Tuominen P, Elovaara E, Husgafvel-Pursiainen K, Karjalainen A, Nurminen T. Methylation of cytochrome P4501A1 promoter in the lung is associated with tobacco smo‌ki‌ng. Cancer Res 2003; 63(24): 8623-28.
23. Dogan MV, Shields B, Cutrona C, Gao L, Gibbons FX, Simons R, et al. The effect of smoking on DNA methylation of peripheral blood mono‌nuclear cells from African American women. BMC Genomics 2014; 15(1): 151.
24. Lee KW, Pausova Z. Cigarette smoking and DNA methylation. Front Genet 2013; 4: 132.
25. Wan ES, Qiu W, Baccarelli A, Carey VJ, Bacherman H, Rennard SI, et al. Cigarette smoking behaviors and time since quitting are associated with differential DNA methylation across the hu‌man genome. Hum Mol Genet 2012; 21(13): 3073-82.
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sadeghi-Amiri L, Barzegar A, Nikbakhsh-Zati N, Mehraban P. Study of the correlation between CYP1A1 gene promoter methylation and smoking in gastric cancer patients. Feyz. 2019; 23 (1) :61-67
URL: http://feyz.kaums.ac.ir/article-1-3732-en.html


Volume 23, Issue 1 (Bimonthly 2019) Back to browse issues page
مجله علمی پژوهشی فیض ::: دانشگاه علوم پزشکی کاشان KAUMS Journal ( FEYZ )
Persian site map - English site map - Created in 0.06 seconds with 32 queries by YEKTAWEB 3937